BioNTech announced that the Supervisory Board has appointed James Ryan, Ph.D., to the Management Board as Chief Legal Officer, effective September 1. As part of the Management Board, James Ryan will continue to lead the company’s corporate legal strategy and global legal operations including transactions, corporate governance, securities, intellectual property, insurance, data privacy, among others. Prior to his appointment to the Management Board, James Ryan served as the company’s General Counsel and Senior Vice President Legal & IP.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BNTX:
- BioNTech Expands Management Board by Appointing James Ryan as Chief Legal Officer
- BioNTech price target lowered to $180 from $181 at H.C. Wainwright
- Pfizer Stock’s (NYSE:PFE) Future: Not as Bleak as You’d Think
- BioNTech price target lowered to $200 from $203 at Canaccord
- BioNTech (NASDAQ: BNTX) Declines after Q2 Sales Take a Hit
